CLINICAL_TRIALS
trial_result
· 2013-03-12
Clinical Trial Update: Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS) [Phase 1]
Summary
Phase 1 trial PLANETAS evaluating the investigational autoimmune drug cT-p13 in Ankylosing Spondylitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celltrion | Conditions: Ankylosing Spondylitis | Phase 1 | Status: COMPLETED